BRUKER CORP (BRKR)
US1167941087 - Common Stock
BRKR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. BRKR has an excellent profitability rating, but there are concerns on its financial health. BRKR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year BRKR was profitable.
BRKR had a positive operating cash flow in the past year.
Each year in the past 5 years BRKR has been profitable.
BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
BRKR has a Return On Assets of 4.99%. This is amongst the best in the industry. BRKR outperforms 81.82% of its industry peers.
The Return On Equity of BRKR (16.87%) is better than 90.91% of its industry peers.
BRKR has a better Return On Invested Capital (5.81%) than 76.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKR is in line with the industry average of 10.42%.
The last Return On Invested Capital (5.81%) for BRKR is well below the 3 year average (12.21%), which needs to be investigated, but indicates that BRKR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.99% | ||
| ROE | 16.87% | ||
| ROIC | 5.81% |
ROA(3y)8.62%
ROA(5y)7.63%
ROE(3y)27.84%
ROE(5y)24.34%
ROIC(3y)12.21%
ROIC(5y)11.26%
1.3 Margins
BRKR's Profit Margin of 9.41% is amongst the best of the industry. BRKR outperforms 81.82% of its industry peers.
In the last couple of years the Profit Margin of BRKR has grown nicely.
BRKR has a better Operating Margin (11.42%) than 70.91% of its industry peers.
In the last couple of years the Operating Margin of BRKR has grown nicely.
BRKR has a Gross Margin (49.31%) which is in line with its industry peers.
In the last couple of years the Gross Margin of BRKR has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.42% | ||
| PM (TTM) | 9.41% | ||
| GM | 49.31% |
OM growth 3Y6.87%
OM growth 5Y2.33%
PM growth 3Y21.98%
PM growth 5Y8.74%
GM growth 3Y2.66%
GM growth 5Y1.51%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BRKR is still creating some value.
Compared to 1 year ago, BRKR has less shares outstanding
The number of shares outstanding for BRKR has been reduced compared to 5 years ago.
Compared to 1 year ago, BRKR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.66 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.66, BRKR is in line with its industry, outperforming 54.55% of the companies in the same industry.
The Debt to FCF ratio of BRKR is 14.66, which is on the high side as it means it would take BRKR, 14.66 years of fcf income to pay off all of its debts.
BRKR has a Debt to FCF ratio of 14.66. This is comparable to the rest of the industry: BRKR outperforms 58.18% of its industry peers.
A Debt/Equity ratio of 1.25 is on the high side and indicates that BRKR has dependencies on debt financing.
The Debt to Equity ratio of BRKR (1.25) is worse than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | 14.66 | ||
| Altman-Z | 2.66 |
ROIC/WACC0.54
WACC10.76%
2.3 Liquidity
BRKR has a Current Ratio of 1.66. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.66, BRKR is doing worse than 70.91% of the companies in the same industry.
BRKR has a Quick Ratio of 1.66. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
BRKR's Quick ratio of 0.71 is on the low side compared to the rest of the industry. BRKR is outperformed by 89.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.66 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
BRKR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.49%.
BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.87% yearly.
The Revenue has grown by 15.00% in the past year. This is quite good.
Measured over the past years, BRKR shows a quite strong growth in Revenue. The Revenue has been growing by 9.36% on average per year.
EPS 1Y (TTM)-6.49%
EPS 3Y25.68%
EPS 5Y13.87%
EPS Q2Q%-18.92%
Revenue 1Y (TTM)15%
Revenue growth 3Y14.26%
Revenue growth 5Y9.36%
Sales Q2Q%16.37%
3.2 Future
BRKR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.36% yearly.
BRKR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.67% yearly.
EPS Next Y-9.24%
EPS Next 2Y1.64%
EPS Next 3Y6.33%
EPS Next 5Y11.36%
Revenue Next Year14.99%
Revenue Next 2Y11.33%
Revenue Next 3Y9.7%
Revenue Next 5Y8.67%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 23.29, the valuation of BRKR can be described as rather expensive.
Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 87.27% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BRKR to the average of the S&P500 Index (29.20), we can say BRKR is valued slightly cheaper.
BRKR is valuated rather expensively with a Price/Forward Earnings ratio of 20.61.
BRKR's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRKR is cheaper than 83.64% of the companies in the same industry.
BRKR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.29 | ||
| Fwd PE | 20.61 |
4.2 Price Multiples
BRKR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BRKR is cheaper than 83.64% of the companies in the same industry.
65.45% of the companies in the same industry are more expensive than BRKR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 55.21 | ||
| EV/EBITDA | 20.06 |
4.3 Compensation for Growth
The excellent profitability rating of BRKR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.68
EPS Next 2Y1.64%
EPS Next 3Y6.33%
5. Dividend
5.1 Amount
With a yearly dividend of 0.36%, BRKR is not a good candidate for dividend investing.
BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.69. BRKR pays more dividend than 90.91% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.21, BRKR's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
5.2 History
The dividend of BRKR has a limited annual growth rate of 4.62%.
BRKR has been paying a dividend for over 5 years, so it has already some track record.
BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.62%
Div Incr Years0
Div Non Decr Years7
5.3 Sustainability
9.81% of the earnings are spent on dividend by BRKR. This is a low number and sustainable payout ratio.
BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP9.81%
EPS Next 2Y1.64%
EPS Next 3Y6.33%
BRUKER CORP
NASDAQ:BRKR (11/22/2024, 8:26:56 PM)
After market: 57.07 0 (0%)57.07
+0.85 (+1.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.65B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.36% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.29 | ||
| Fwd PE | 20.61 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.99% | ||
| ROE | 16.87% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 11.42% | ||
| PM (TTM) | 9.41% | ||
| GM | 49.31% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.66 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-6.49%
EPS 3Y25.68%
EPS 5Y
EPS Q2Q%
EPS Next Y-9.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15%
Revenue growth 3Y14.26%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y